(Q39817760)

14 September 2017

Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture (English)

1 reference

14 September 2017

0 references

Derouin F

1

1 reference

14 September 2017

Chastang C

series ordinal

2

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 March 1988

1 reference

14 September 2017

5

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

14 September 2017

32

1 reference

14 September 2017

3

1 reference

14 September 2017

303-307

1 reference

Chemotherapeutic implications of polyamine biosynthesis inhibition

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172164

New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172164

Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172164

Enzyme immunoassay for evaluation of Toxoplasma gondii growth in tissue culture

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172164

A method to evaluate the capacity of monocytes and macrophages to inhibit multiplication of an intracellular pathogen

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172164

Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172164

The Effect of Trimethoprim and Sulfamethoxazole on Toxoplasma Gondii in Vitro and in Vivo *

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172164

Congenital toxoplasmosis. A prospective study of 378 pregnancies

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172164

A comparison of Ultrax, Diazil, Bactrim and Spiramycin in experimental toxoplasmosis in mice (author's transl)

20 August 2018

1 reference

12 December 2020

Spiramycin ; therapeutic value in humans. (author's transl)

1 reference

12 December 2020

Inhibition of Growth ofGiardia lambliaby Difluoromethylornithine, a Specific Inhibitor of Polyamine Biosynthesis1

1 reference

12 December 2020

[Experimental toxoplasmosis in mice. Comparative activity of clindamycin, midecamycin, josamycin, spiramycin, pyrimethamine-sulfadoxine, and trimethoprim-sulfamethoxazole]

1 reference

12 December 2020

Difluoromethylornithine and formycin B in toxoplasmosis

1 reference

12 December 2020

Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.32.3.303

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

3284458

1 reference